![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ProciseDx Earns CE Mark for C-Reactive Protein Assay
ProciseDx Earns CE Mark for C-Reactive Protein Assay
ProciseDx has earned the CE Mark for its Procise C reactive protein (CRP) assay, a point-of-care diagnostic used with its ProciseDx rapid diagnostic testing platform.
CRP is often used as a biomarker to evaluate patients for infection or inflammation caused by autoimmune diseases. It can also be used to predict a patient’s future risk of cardiovascular disease.
The diagnostic system, which is about the size of a shoebox, uses a finger prick of blood or stool sample to deliver test results in two to five minutes.
Upcoming Events
-
21Oct